Last kr363.00 DKK
Change Today +11.00 / 3.13%
Volume 17.5K
AMBUB On Other Exchanges
Symbol
Exchange
Copenhagen
As of 11:03 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

ambu a/s-b (AMBUB) Snapshot

Open
kr355.00
Previous Close
kr352.00
Day High
kr363.00
Day Low
kr353.50
52 Week High
04/10/14 - kr375.00
52 Week Low
06/24/13 - kr174.00
Market Cap
4.3B
Average Volume 10 Days
12.8K
EPS TTM
kr3.34
Shares Outstanding
10.2M
EX-Date
12/13/13
P/E TM
108.7x
Dividend
kr1.25
Dividend Yield
0.34%
Current Stock Chart for AMBU A/S-B (AMBUB)

Related News

No related news articles were found.

ambu a/s-b (AMBUB) Related Businessweek News

No Related Businessweek News Found

ambu a/s-b (AMBUB) Details

Ambu A/S provides healthcare solutions in anesthesia, patient monitoring and diagnostics, and emergency care fields worldwide. The company offers anesthesia products, including laryngeal masks, ventilation bags, face masks for artificial ventilation, scopes for visualization, anesthesia tubes, and pumps for palliative care; patient monitoring and diagnostics products, such as single-use electrodes for neurological and cardiological examinations, and tubes and needles; emergency care products comprising neck collars, manikins, and other equipment for first-aid training; conductive adhesive gels for use in the production of skin-contacting biomedical electrodes; and single-use videoscopes. The company serves hospitals, clinics, rescue services and sleep laboratories, aid organizations, and the armed forces. It sells and exports its products through direct sales and distributors. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

2,250 Employees
Last Reported Date: 02/4/14
Founded in 1937

ambu a/s-b (AMBUB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ambu a/s-b (AMBUB) Key Developments

Ambu A/S Reports Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2013; Provides Free Cash Flow Guidance for the Year 2014

Ambu A/S reported unaudited consolidated earnings results for the first quarter ended December 31, 2013. For the quarter, the company reported net profit of DKK 3 million or DKK 0.25 per diluted share on revenues of DKK 342 million compared to net profit of DKK 11 million or DKK 1.01 per diluted share on revenues of DKK 269 million a year ago. Profit before interest, tax, depreciation and amortization (EBITDA), before special items was DKK 35 million compared to DKK 41 million a year ago. Operating profit (EBIT) before special items was DKK 16 million compared to DKK 27 million a year ago. Operating profit (EBIT) was DKK 16 million compared to DKK 21 million a year ago. Profit before tax was DKK 4 million compared to DKK 18 million a year ago. Cash flows from operating activities were DKK 17 million compared to cash outflow of DKK 6 million a year ago. Purchase of non-current assets were DKK 17 million compared to DKK 13 million a year ago. Return on equity was 6.1% compared to 15.1% a year ago. At the end of the quarter, the total financial net debt was DKK 732 million. For the year 2014, the company expected free cash flow to be in the range of DKK 100 million to DKK 120 million.

Ambu A/S, Q1 2014 Earnings Call, Feb 04, 2014

Ambu A/S, Q1 2014 Earnings Call, Feb 04, 2014

Ambu A/S Proposes Dividend for Fiscal Year 2013

Ambu A/S announced that the Board of Directors proposes to the annual general meeting that a dividend be declared of DKK 1.25 per share for 2012/13, corresponding to 31% of the profit for the year. The Board of Directors deems this level to be reasonable in light of company's financial resources and the expected results in the next financial year. The Board of Directors is also basing its proposal on the fact that the results for 2012/13 were challenged by a number of extraordinary factors following the acquisition of King Systems.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMBUB:DC kr363.00 DKK +11.00

AMBUB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Repro-Med Systems Inc $0.21 USD +0.0058
View Industry Companies
 

Industry Analysis

AMBUB

Industry Average

Valuation AMBUB Industry Range
Price/Earnings 100.0x
Price/Sales 3.0x
Price/Book 6.8x
Price/Cash Flow 92.9x
TEV/Sales 1.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBU A/S-B, please visit www.ambu.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.